Dr. Robert Stein, MD, PhD

Accelerating Drug Development with AI and Smart Imaging Imaging Protocol Design and Optimal Endpoint Selection Cloud Platform DYNAMIKA for Central Data Management and Review Superior Science and Risk-Sharing Business Models
Bob-Stein_RD_135

Dr. Robert Stein, MD, PhD

Scientific Expert in Pre-Clinical Development and Translational Medicine
IAG’s Scientific Expert in preclinical development and translational medicine. Dr. Stein began his career at Merck, Sharp and Dohme. He holds an MD and a PhD in Physiology & Pharmacology from Duke University. Over his 30 years of experience in the biopharmaceutical industry he played a pivotal role in bringing to the market Sustiva®, Fablyn®, Viviant®, PanRetin®, TargRetin®, Promacta® and Eliquis®. Dr. Stein is helping our bio-pharmaceutical partners to shape clinical development strategy, discovery and optimization technology platforms and portfolio in oncology and immune-oncology programs.